Screener
AnaptysBio, Inc. ANAB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable and other liabilities | (17,819) | (24,034) |
| Deferred income | — | 3,544 |
| Operating lease liabilities | (499) | (462) |
| Net cash used in operating activities | (25,919) | (10,700) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of investments | — | (122,547) |
| Sales and maturities of investments | 35,000 | 137,429 |
| Purchases of property and equipment | (17) | (35) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s operating cash flow?
- AnaptysBio, Inc. (ANAB) reported operating cash flow of -$25.92M in Q1 2026.
- How has AnaptysBio, Inc.'s operating cash flow changed year-over-year?
- AnaptysBio, Inc.'s operating cash flow decreased by 142.2% year-over-year, from -$10.7M to -$25.92M.
- What is the long-term trend for AnaptysBio, Inc.'s operating cash flow?
- Over 3 years (2022 to 2025), AnaptysBio, Inc.'s operating cash flow has grown at a -35.6% compound annual growth rate (CAGR), from -$73.59M to $19.7M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about AnaptysBio, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude